A. Schmidt

Lack of Bone Neoplasms and Persistence of Bone Efficacy in Cynomolgus Macaques After Long‐Term Treatment With Teriparatide [rhPTH(1‐34)]

J. Vahle, M. Westmore, Masahiko Sato, 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

New bone formation with teriparatide [human parathyroid hormone-(1-34)] is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats.

J. Hoover, H. Bryant, W. Jee, 2003, Endocrinology.

Raloxifene and teriparatide (hPTH 1-34) have complementary effects on the osteopenic skeleton of ovariectomized rats

H. Bryant, W. Jee, Y. Ma, 2009, Journal of Bone and Mineral Metabolism.

Raloxifene and Vitamin K2 Combine to Improve the Femoral Neck Strength of Ovariectomized Rats

J. Iwamoto, T. Takeda, M. Sato, 2005, Calcified Tissue International.

Longitudinal in vivo analysis of the region-specific efficacy of parathyroid hormone in a rat cortical defect model.

A. Geiser, M. Westmore, Y. Ma, 2009, Endocrinology.

Teriparatide [PTH(1–34)] Strengthens the Proximal Femur of Ovariectomized Nonhuman Primates Despite Increasing Porosity

E. Glass, C. Turner, J. Vahle, 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

A nonsecosteroidal vitamin D receptor ligand with improved therapeutic window of bone efficacy over hypercalcemia

S. Iturria, C. Montrose‐Rafizadeh, H. Bryant, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Abnormal bone architecture and biomechanical properties with near-lifetime treatment of rats with PTH.

J. Vahle, M. Sato, M. Westmore, 2002, Endocrinology.